Shire wins FDA approval for new ADHD drug
June 21, 2017 at 09:01 AM EDT
The company, which has its U.S. headquarters in Lexington, first sought approval for the drug in 2006 but was rejected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.